A recent World Health Organisation report states that approximately 800 women die in pregnancy or childbirth every day and 99% of these occur in low and middle-income countries (LMICs). Obstetric haemorrhage, sepsis and pregnancy associated hypertension are the most common causes. Simple and cost-effective interventions are available but delays in recognising maternal compromise and initiating management result in poor maternal outcomes. In each of these conditions, accurate measurement of vital signs is key to early recognition and timely intervention.
The primary aim of the CRADLE project was to develop a device capable of accurately detecting abnormalities in vital signs (including blood pressure (BP) and heart rate (HR)) that was also suitable for introduction into LMICs. CRADLE then extended this aim to prospectively evaluate the device’s ability to reduce maternal mortality and morbidity by increasing timely referral and initiation of interventions. For more information on CRADLE please visit their new wesbite: http://cradletrial.com/